Evidence map›Paper›PMID 38032411›Full record

ArticleArchives of gynecology and obstetrics2024

Effect of GnRH agonist trigger with or without low-dose hCG on reproductive outcomes for PCOS women with freeze-all strategy: a propensity score matching study.

Qiaofeng Wang, Qi Wan, Tian Li, Xuejiao Wang, Yuling Hu, Zhaohui Zhong, Kexue Pu, Yubin Ding, Xiaojun Tang

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of gynecology and obstetrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Minimising OHSS in women with PCOS.Frontiers in endocrinology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Qiaofeng Wang *Department of Epidemiology, School of Public Health, Chongqing Medical University, Chongqing, China.
Qi Wan *Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Chengdu, China.
Tian LiDepartment of Reproductive Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xuejiao WangDepartment of Reproductive Center, Chengdu Jinjiang Hospital for Women's and Children's Health, Chengdu, China.
Yuling HuDepartment of Reproductive Center, Chengdu Jinjiang Hospital for Women's and Children's Health, Chengdu, China.
Zhaohui ZhongDepartment of Epidemiology, School of Public Health, Chongqing Medical University, Chongqing, China.
Kexue PuChongqing Engineering Research Center for Clinical Big Data and Drug Evaluation, College of Medical Informatics, Chongqing Medical University, Chongqing, China.
Yubin DingJoint International Research Laboratory of Reproduction and Development of the Ministry of Education of China, School of Public Health, Chongqing Medical University, Chongqing, China. dingyb@cqmu.edu.cn.
Xiaojun TangDepartment of Epidemiology, School of Public Health, Chongqing Medical University, Chongqing, China. tangxiaojun@cqmu.edu.cn.ORCID 0000-0003-3486-1020
Chongqing Public Health Medical Center · CNChengdu Women's and Children's Central Hospital · CNChongqing Medical University · CNChongqing University · CNSichuan University · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

Chongqing Key Laboratory of Birth Defects and Reproductive Health, Chongqing Population and Family Planning Science and Technology Research Institute 2021yjy-kfkt-0008
6 · The paper itself

Abstract

purposeThis study aimed to compare the effect of gonadotropin-releasing hormone agonist (GnRHa) trigger alone versus dual trigger comprising GnRHa and low-dose human chorionic gonadotropin (hCG) on reproductive outcomes in patients with polycystic ovary syndrome (PCOS) who received the freeze-all strategy.

methodsA total of 615 cycles were included in this retrospective cohort study. Propensity score matching (PSM) was performed to control potential confounding factors between GnRHa-trigger group (0.2 mg GnRHa) and dual-trigger group (0.2 mg GnRHa plus 1000/2000 IU hCG) in a 1:1 ratio. Multivariate logistic regression was applied to estimate the association between trigger methods and reproductive outcomes.

resultsAfter PSM, patients with dual trigger (n = 176) had more oocytes retrieved, mature oocytes, and 2PN embryos compared to that with GnRHa trigger alone. However, the oocytes maturation rate, normal fertilization rate, and frozen embryos between the two groups were not statistically different. The incidence of ovarian hyperstimulation syndrome (OHSS) (14.8% vs. 2.8%, P < 0.001) and moderate/severe OHSS (11.4% vs. 1.7%, P < 0.001) were significantly higher in dual-trigger group than in GnRHa-alone group. Logistic regression analysis showed the adjusted odds ratio of dual trigger was 5.971 (95% confidence interval 2.201-16.198, P < 0.001) for OHSS. The pregnancy and single neonatal outcomes were comparable between the two groups (P > 0.05).

conclusionFor PCOS women with freeze-all strategy, GnRHa trigger alone decreased the risk of OHSS without damaging oocyte maturation and achieved satisfactory pregnancy outcomes.

Indexed as

Ovarian Hyperstimulation SyndromePolycystic Ovary SyndromeChorionic GonadotropinFemaleFertilization in VitroGonadotropin-Releasing HormoneHumansInfant, NewbornOocytesOvulation InductionPregnancyPregnancy RatePropensity ScoreRetrospective StudiesChorionic GonadotropinGonadotropin-Releasing HormoneFreeze-all strategyGnRH agonisthCGPCOSPropensity score matching

Identifiers

PMID38032411
OpenAlexW4389179413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.